Give now to expand and protect access to abortion beyond Roe.

Blog

Mar 23

Meet RHAP’s Newest Board Members!

RHAP’s Board is growing! We are excited to be joined by new leaders who are expanding our board’s skills, perspective, and ideas! Get to know our new RHAPers:   Sky Lee, MD AAHIVS (she/her) Sky Lee is a board-certified Family and Addiction Medicine physician and certified by American Academy of HIV Medicine to provide HIV…

Mar 16

Update On Our Patient Education Resources

RHAP provides free, evidence-based clinical tools and patient education resources for clinicians and patients on abortion, contraception, and early pregnancy loss (miscarriage) care. These resources are provided in a variety of different languages, with more resources being continuously translated/updated. We field-test all of our new resources and new translations with clinicians and patients to make…

Mar 09

Advocacy Round Up!

Advocacy Round-Up: Take action in 5 minutes or less! We know that with everything going on these days in the government, the media, the workplace, our personal lives, and more, keeping up on what’s happening in reproductive health, rights, and justice can be difficult. Check out a few major updates – and some easy, quick…

Mar 09

Celebrate Abortion Providers All Month Long!

March 10th is National Abortion Provider Appreciation Day – and RHAP is celebrating all month long! Join us in celebrating the resilience, compassion, and dedication to patient-centered care of abortion care clinicians. To our clinician community: We thank you, we value you, and we want to show our gratitude this Abortion Provider Appreciation Day! This…

Feb 16

Roe v. Wade in 2022

January 22nd marked the 49th anniversary of Roe v. Wade, the landmark Supreme Court decision that established legal abortion across the United States.  RHAP and RHEDI started as one organization based in New York City called the Access Project. For over twenty years, we have been honoring the Roe v. Wade court decision by gathering…

Feb 02

Update: FDA’s Decision on Mifepristone REMS

The US Food and Drug Administration (FDA) has long regulated mifepristone, also known as the abortion pill, under a Risk Evaluation and Mitigation Strategy (REMS). Despite mifepristone and misoprostol being one safe, effective way to provide abortion and early pregnancy loss (EPL) care, the FDA restrictions have limited where and who can provide this essential…

Jan 26

2021 Year-End Campaign

Thanks to over 400 supporters, we raised over $260,000 for our 2021 year-end campaign! Your support, and the impact it has on clinicians and patients, keep us inspired. Thank you for taking a stand for reproductive health care and committing to expand access to this necessary care.  We are ready to take on 2022 with…

Jan 26

2022 – I’m ready!

2022 is going to be a heck of a year for abortion access. While it’s impossible to predict the future, the reality represented in this map is rapidly approaching. At RHAP – and across the reproductive health, rights, and justice movements – we are gearing up to face a future where Roe v. Wade is…